- Investor's Business Daily•3 hours ago
The buzz around biotechs amped up a notch in the past week as Kite Pharma (KITE) and G.W. Pharmaceuticals (GWPH) socked away double-digit gains. Kite soared 10% in massive trade on Tuesday after announcing its KTE-C19 treatment showed a 47% complete remission rate in patients with the most common form of Non-Hodgkin lymphoma. The gain left shares up nearly 5%...
- Market Realist•6 hours ago
Revenue growth drivers Previously we discussed Pfizer’s (PFE) revenues and growth trends. To better understand the factors affecting growth, let’s now explore Pfizer’s product portfolio and pipeline. The ...
Pfizer Inc. (PFE)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||33.92 x 26000|
|Ask||33.93 x 9000|
|Day's Range||33.40 - 34.02|
|52wk Range||28.25 - 37.39|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||30.04|
|Avg Vol (3m)||19,171,578|
|Dividend & Yield||1.20 (3.53%)|